pubmed-article:21145860 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:21145860 | lifeskim:mentions | umls-concept:C0019169 | lld:lifeskim |
pubmed-article:21145860 | lifeskim:mentions | umls-concept:C0007600 | lld:lifeskim |
pubmed-article:21145860 | lifeskim:mentions | umls-concept:C0014279 | lld:lifeskim |
pubmed-article:21145860 | lifeskim:mentions | umls-concept:C0227525 | lld:lifeskim |
pubmed-article:21145860 | lifeskim:mentions | umls-concept:C2239176 | lld:lifeskim |
pubmed-article:21145860 | lifeskim:mentions | umls-concept:C0039194 | lld:lifeskim |
pubmed-article:21145860 | lifeskim:mentions | umls-concept:C1518174 | lld:lifeskim |
pubmed-article:21145860 | lifeskim:mentions | umls-concept:C1521840 | lld:lifeskim |
pubmed-article:21145860 | pubmed:issue | 1 | lld:pubmed |
pubmed-article:21145860 | pubmed:dateCreated | 2011-6-17 | lld:pubmed |
pubmed-article:21145860 | pubmed:abstractText | Virus-specific T cells capable of controlling HBV and eliminating hepatocellular carcinoma (HCC) expressing HBV antigens are deleted or dysfunctional in patients with chronic HBV or HBV-related HCC. The goal of this study was to determine if T cell receptor (TCR) gene transfer can reconstitute HBV-specific T cell immunity in lymphocytes of chronic HBV patients and investigate whether HCC cells with natural HBV-DNA integration can be recognized by genetically modified T cells. | lld:pubmed |
pubmed-article:21145860 | pubmed:language | eng | lld:pubmed |
pubmed-article:21145860 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21145860 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:21145860 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21145860 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21145860 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21145860 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:21145860 | pubmed:month | Jul | lld:pubmed |
pubmed-article:21145860 | pubmed:issn | 0168-8278 | lld:pubmed |
pubmed-article:21145860 | pubmed:author | pubmed-author:XueShao-AnSA | lld:pubmed |
pubmed-article:21145860 | pubmed:author | pubmed-author:BertolettiAnt... | lld:pubmed |
pubmed-article:21145860 | pubmed:author | pubmed-author:RuedlChristia... | lld:pubmed |
pubmed-article:21145860 | pubmed:author | pubmed-author:MainiMala KMK | lld:pubmed |
pubmed-article:21145860 | pubmed:author | pubmed-author:LimSeng GeeSG | lld:pubmed |
pubmed-article:21145860 | pubmed:author | pubmed-author:GehringAdam... | lld:pubmed |
pubmed-article:21145860 | pubmed:author | pubmed-author:StaussHansH | lld:pubmed |
pubmed-article:21145860 | pubmed:author | pubmed-author:TeohDeniseD | lld:pubmed |
pubmed-article:21145860 | pubmed:author | pubmed-author:KohSareneS | lld:pubmed |
pubmed-article:21145860 | pubmed:author | pubmed-author:ChiaAdelineA | lld:pubmed |
pubmed-article:21145860 | pubmed:author | pubmed-author:HoZi ZongZZ | lld:pubmed |
pubmed-article:21145860 | pubmed:copyrightInfo | Copyright © 2010 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved. | lld:pubmed |
pubmed-article:21145860 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:21145860 | pubmed:volume | 55 | lld:pubmed |
pubmed-article:21145860 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:21145860 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:21145860 | pubmed:pagination | 103-10 | lld:pubmed |
pubmed-article:21145860 | pubmed:meshHeading | pubmed-meshheading:21145860... | lld:pubmed |
pubmed-article:21145860 | pubmed:meshHeading | pubmed-meshheading:21145860... | lld:pubmed |
pubmed-article:21145860 | pubmed:meshHeading | pubmed-meshheading:21145860... | lld:pubmed |
pubmed-article:21145860 | pubmed:meshHeading | pubmed-meshheading:21145860... | lld:pubmed |
pubmed-article:21145860 | pubmed:meshHeading | pubmed-meshheading:21145860... | lld:pubmed |
pubmed-article:21145860 | pubmed:meshHeading | pubmed-meshheading:21145860... | lld:pubmed |
pubmed-article:21145860 | pubmed:meshHeading | pubmed-meshheading:21145860... | lld:pubmed |
pubmed-article:21145860 | pubmed:meshHeading | pubmed-meshheading:21145860... | lld:pubmed |
pubmed-article:21145860 | pubmed:meshHeading | pubmed-meshheading:21145860... | lld:pubmed |
pubmed-article:21145860 | pubmed:meshHeading | pubmed-meshheading:21145860... | lld:pubmed |
pubmed-article:21145860 | pubmed:meshHeading | pubmed-meshheading:21145860... | lld:pubmed |
pubmed-article:21145860 | pubmed:meshHeading | pubmed-meshheading:21145860... | lld:pubmed |
pubmed-article:21145860 | pubmed:meshHeading | pubmed-meshheading:21145860... | lld:pubmed |
pubmed-article:21145860 | pubmed:meshHeading | pubmed-meshheading:21145860... | lld:pubmed |
pubmed-article:21145860 | pubmed:meshHeading | pubmed-meshheading:21145860... | lld:pubmed |
pubmed-article:21145860 | pubmed:meshHeading | pubmed-meshheading:21145860... | lld:pubmed |
pubmed-article:21145860 | pubmed:year | 2011 | lld:pubmed |
pubmed-article:21145860 | pubmed:articleTitle | Engineering virus-specific T cells that target HBV infected hepatocytes and hepatocellular carcinoma cell lines. | lld:pubmed |
pubmed-article:21145860 | pubmed:affiliation | Singapore Institute for Clinical Sciences, Agency for Science Technology and Research, Singapore. | lld:pubmed |
pubmed-article:21145860 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:21145860 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |